474O Efficacy and safety of first-line durvalumab (D) ±...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

474O Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC

Cho, B C, Lee, K H, Ahn, M-J, Geater, S Lucien, Ngoc, T V, Wang, C-C, Cho, E K, Lee, J S, Sriuranpong, V, Bui, Q, Clarke, S, Kuyama, S, Nakagawa, K, Liu, F, Clemett, D, Scheuring, U, Peters, S, Rizvi,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz437
Date:
November, 2019
File:
PDF, 127 KB
2019
Conversion to is in progress
Conversion to is failed